行情

NWBO

NWBO

Northwest Bio
OTCMQB

实时行情|Nasdaq Last Sale

0.700
-0.104
-12.95%
已收盘, 15:59 05/16 EDT
开盘
0.780
昨收
0.804
最高
0.780
最低
0.604
成交量
405.18万
成交额
287.62万
52周最高
2.150
52周最低
0.386
市值
6.72亿
市盈率(TTM)
3.582
分时
5日
1月
3月
1年
5年
Northwest Bio plunges after late-stage data for lead candidate in brain cancer
The shares of Northwest Biotherapeutics (OTCQB:NWBO) reached a 52-week low on Tuesday after the clinical-stage immunotherapy company announced a presentation with Phase 3 data for its lead asset DCVax-L in
Seekingalpha · 6天前
Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma Today At New York Academy of Sciences To Be Available Online As Well
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported that, as previously announced, a presentation entitled "Autologous Tumor Lysate-Loaded Dendritic C...
PR Newswire · 6天前
Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciences
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported that a presentation entitled "Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination for Gliobl...
PR Newswire · 05/04 15:35
If You Invested $1000 In Northwest Biotherapeutics 5 Years Ago, Here's How Much You Would Have Today
Northwest Biotherapeutics (OTC:NWBO) has outperformed the market over the past 5 years by 42.99% on an annualized basis producing an average annual return of 54.57%. Currently, Northwest Biotherapeutics has a market capitalization of $1.42 billion.
Benzinga · 05/03 15:03
Northwest stock rises 9% as company begins cancer vaccine production at UK facility
Northwest Biotherapeutics (OTCQB:NWBO +7.6%) began production of its first dendritic cell cancer vaccine for a compassionate use patient at its production facility in Sawston, U.K. The company said the milestone follows
Seekingalpha · 02/17 14:49
Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced commencement of production of its first dendritic cell cancer vaccine for a compassionate u...
PR Newswire · 02/17 14:20
Northwest Biotherapeutics Announces MHRA Approval Of License for GMP Manufacturing At Sawston, UK Facility
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that approval has been received from the UK Medicines and Healthcare Products Regulatory Ag...
PR Newswire · 2021/12/21 14:24
Northwest Biotherapeutics 获得 1500 万美元的股票购买权融资
Northwest Biotherapeutics (OTCQB:NWBO +12.3%) has closed on $15M financing, which brings the company's cash reserves above $20M. The financing is in the form of a 22-month loan which requires no
Seekingalpha · 2021/11/29 16:11
更多
暂无数据
了解NWBO最新的财务预测,通过NWBO每股收益,每股净资产,每股现金流等数据分析Northwest Bio近期的经营情况,然后做出明智的投资选择。
暂无数据
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.23%
制药与医学研究
+1.02%
高管信息
Chairman/President/Chief Executive Officer/Chief Financial Officer/Chief Accounting Officer/Director
Linda Powers
Senior Vice President/General Counsel
Leslie Goldman
Chief Technology Officer
Marnix Bosch
Chief Scientific Officer/Director
Alton Boynton
Lead Director/Independent Director
Jerry Jasinowski
Independent Director
J. Cofer Black
Independent Director
Navid Malik
暂无数据
暂无数据
NWBO 简况
Northwest Biotherapeutics, Inc.是一家生物技术公司。该公司主要开发治疗癌症的免疫治疗产品。该公司的产品DCVax-L治疗可手术切除肿瘤的所有实体瘤癌。该公司的产品DCVax-Direct治疗所有实体肿瘤癌。该公司在60多个试验点对其主导产品DCVax-L开展第一阶段临床实验,以治疗多形性胶质母细胞瘤(GBM)疾病。该公司正通过60位患者对另一种产品DCVax-Direct进行第一/二阶段临床实验,以治疗所有类型的晚期实体瘤疾病。DCVax-Direct已通过40位患者完成第一阶段试验。该公司正在为DCVax-Direct的第二阶段试验做准备工作。该公司的平台技术DCVax使用活化的树突状细胞激活患者自身的免疫系统(包括T细胞、B细胞和抗体与自然杀伤细胞等),来攻击癌细胞抗击癌症。

微牛提供Northwest Biotherapeutics, Inc(OTCMQB-NWBO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NWBO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NWBO股票基本功能。